Anxiety disorders are associated with a high social burden worldwide. Recently, increasing evidence suggests that nuclear factor kappa B (NF-jB) has significant implications for psychiatric diseases, including anxiety and depressive disorders. However, the molecular mechanisms underlying the role of NF-jB in stress-induced anxiety behaviors are poorly understood. In this study, we show that chronic mild stress (CMS) and glucocorticoids dramatically increased the expression of NF-jB subunits p50 and p65, phosphorylation and acetylation of p65, and the level of nuclear p65 in vivo and in vitro, implicating activation of NF-jB signaling in chronic stress-induced pathological processes. Using the noveltysuppressed feeding (NSF) and elevated-plus maze (EPM) tests, we found that treatment with pyrrolidine dithiocarbamate (PDTC; intra-hippocampal infusion), an inhibitor of NF-jB, rescued the CMS-or glucocorticoid-induced anxiogenic behaviors in mice. Microinjection of PDTC into the hippocampus reversed CMS-induced up-regulation of neuronal nitric oxide synthase (nNOS), carboxy-terminal PDZ ligand of nNOS (CAPON), and dexamethasone-induced ras protein 1 (Dexras1) and dendritic spine loss of dentate gyrus (DG) granule cells. Moreover, over-expression of CAPON by infusing LV-CAPON-L-GFP into the hippocampus induced nNOSDexras1 interaction and anxiety-like behaviors, and inhibition of NF-jB by PDTC reduced the LV-CAPON-L-GFP-induced
increases in nNOS-Dexras1 complex and anxiogenic-like effects in mice. These findings indicate that hippocampal NF-jB mediates anxiogenic behaviors, probably via regulating the association of nNOS-CAPON-Dexras1, and uncover a novel approach to the treatment of anxiety disorders.
Keywords: anxiety, chronic stress, glucocorticoids, NF-jB, nNOS-CAPON-Dexras1 interaction. J. Neurochem. (2018) 146, 598--612. Anxiety disorders are characterized by feelings of anxiety (worry about future events) and fear (reaction to current events), including generalized anxiety disorder, panic disorder, phobias, social anxiety disorder, obsessive-compulsive disorder, and posttraumatic stress disorder (Diagnostic and Statistical Manual of the American Psychiatric Association, 2013). Recently, the World Health Organization predicted that 3.6% of the global population suffers from anxiety disorders. A long-term adverse environment and negative life events are considered to be chronic stress, stimulating the release of glucocorticoids from the adrenal gland, which was reported to have a causal association with anxiety (Muller et al. 2003; Martinowich et al. 2007; Shin and Liberzon 2010) . Glucocorticoids, cortisol in humans and non-human primates, and corticosterone in rats and mice, play an important role in the stress response (Persky et al. 1971; Dallman and Jones 1973; Revest et al. 2005) . However, the pathophysiology of anxiety disorders and molecular mechanisms underlying anxietyrelated behaviors are poorly understood.
The hippocampus, one of the components of the limbic system, is implicated structurally and functionally in mood disorders (Warner-Schmidt and Duman 2006) . Neuronal nitric oxide synthase (nNOS), the main NO synthase in the CNS, is expressed abundantly in the hippocampus Dawson et al. 1991) . In line with other reports (Nelson et al. 1995; Miguel and Nunes-de-Souza 2008; Workman et al. 2008) , our previous studies indicate that hippocampal nNOS mediates stress-related affective behaviors by down-regulating glucocorticoid receptors (Zhou et al. 2011) and negatively regulates the function of post-synaptic 5-HT1A receptors (Zhang et al. 2010) . Importantly, our work showed that association of nNOS with its carboxy-terminal PDZ ligand (CAPON) plays a key role in chronic mild stress (CMS)-induced anxiogenic behaviors via Dexras1-ERK signaling and synaptic plasticity (Zhu et al. 2014) . However, the signaling molecules upstream of nNOS-CAPON coupling in regulating anxiety behaviors is still unclear.
Nuclear factor kappa B (NF-jB), a well-known transcription factor, is expressed ubiquitously and activated by diverse stimuli such as inflammatory and stress responses (Hayden and Ghosh 2004; Perkins and Gilmore 2006; Zlatkovi c and Filipovi c 2013) . There are five subunits of NF-jB, including p50 (cleaved from its precursor p105), p52 (cleaved from p100), p65 (RelA), cRel, and RelB, which combine as homoor heterodimers. In the hippocampus, the p50/p65 heterodimer is the predominant form of NF-jB (Bakalkin et al. 1993) . The transcriptional activity of NF-jB is regulated by its subcellular localization through its interaction with IjB. Multiple signals can trigger phosphorylation and degradation of IjBa, the most well characterized IjB, facilitating p65 nuclear translocation and thus activating target gene expression. In addition to the degradation of IjBa, many post-translational modifications also affect the activity of NF-jB (Perkins 2006) . Among these regulatory modifications, phosphorylation of p65 at Ser468, acetylation of p65 at Lys310, and modifications of p65 at other sites are required for the transcriptional activity of NF-jB (Buss et al. 2004a,b; Schwabe and Sakurai 2005; Mattioli et al. 2006; Perkins 2006) . Important roles of NF-jB in regulating anxiety and depressive behaviors and learning and memory have recently been revealed (Kassed and Herkenham 2004; Koo et al. 2010; Cohen et al. 2011; Kaltschmidt and Kaltschmidt 2015; Fan et al. 2016; Pesarico et al. 2016) . Some investigators have provided evidence that NF-jB is implicated in the regulation of nNOS (Li et al. 2013; Baig et al. 2015) . Here, we investigated whether hippocampal NFjB up-regulates the expression and association of nNOS, CAPON, and Dexras1, thereby increasing nNOS-CAPON signaling, and in turn, mediates chronic stress-induced anxiogenic behaviors.
Materials and methods

Animals
Young adult (6-7 weeks, 22-28 g) ICR male mice, newborn (postnatal d P0-P1) ICR mice (research resource identifier, RRID: IMSR_RBRC05979), and young adult (6-7 weeks, 22-28 g) C57BL/6 male mice (RRID:IMSR_JAX:000664) (from Model Animal Research Center of Nanjing University, Nanjing, China) were used in this study. Animals were maintained at a controlled temperature (20 AE 2°C), and housed (12 h light/dark cycle) with access to food and water ad libitum, except when specified otherwise. All procedures involving the use of animals were approved by the Institutional Animal Care and Use Committee of Southeast University (IACUC-20150806) and complied with the ARRIVE guidelines. This study was not pre-registered.
Experimental design
In this study, ICR mice were exposed to CMS. The experiments involving corticosterone (CORT) exposure and virus infection were carried out in C57BL/6 mice. All the mice were numbered by earmarks and were randomly divided into groups using a table of random numbers.
Experiment 1
This experiment was performed to determine the effects of CMS and glucocorticoids on NF-jB signaling. (i) Mice were randomly divided into two groups, including the control and CMS groups. Twenty-four hours after the CMS procedure, the hippocampi were immediately isolated for further biochemical analysis, and the blood from the angulus oculi vessels was collected for CORT concentration detection. (ii) Mice were randomly divided into two groups, including the vehicle-and CORT-treated groups. Twenty-four hours after the last CORT microinjection, the hippocampi were immediately isolated for further biochemical analysis. (iii) Primary cultured hippocampal neurons at seven days in vitro (DIV) were incubated with 10 lM CORT or its vehicle for 24, 48, or 72 h and subsequently collected for further biochemical analysis.
Experiment 2
This experiment was aimed to investigate the effect of hippocampal NF-jB on CMS-induced anxiogenic behaviors. The detailed experimental procedure can be found in Fig. 3 . The mice were randomly assigned to three groups using a randomization table: (i) Vehicle group (n = 10); (ii) CMS + vehicle group (n = 10); (iii) CMS + PDTC group (n = 11). The behaviors were assessed 1 day after the last treatment. The investigators involved in data analysis were blinded to the sample identity. No mice were excluded.
Experiment 3
This experiment was designed to examine the effect of hippocampal NF-jB on glucocorticoid-induced anxiogenic behaviors. The detailed experimental procedure can be found in Fig. 4 . The mice were randomly divided into three groups using a randomization table: (i) Vehicle group (n = 11); (ii) CORT + vehicle group (n = 11); (iii) CORT + PDTC group (n = 12). The behaviors were assessed 1 day after the last microinjection of CORT. The investigators involved in data analysis were blinded to the sample identity. No mice were excluded.
Experiment 4
This experiment was performed to explore the underlying mechanism of hippocampal NF-jB on stress-induced anxiogenic behaviors. The detailed experimental procedure can be found in Fig. 5 . (i) Primary cultured hippocampal neurons were incubated with PDTC at the concentration indicated for 24 h at 7 DIV. Cellular samples were collected for protein detection of nNOS, CAPON, and Dexras1. (ii) Primary cultured hippocampal neurons were incubated with 10 lM CORT with or without 10 lM PDTC for 72 h at 7 DIV, and neurons were collected for further biochemical analysis. (iii) The mice were randomly assigned to three groups according to a randomization table: vehicle group; CMS + vehicle group; CMS + PDTC group. One day after the last treatment, the hippocampus of the mice were immediately isolated for analysis of nNOS, CAPON, and Dexras1. The fresh brains without perfusion were collected for Golgi-Cox staining. (iv) The mice were randomly divided into three groups (LV-GFP + vehicle, LV-CAPON-L-GFP + vehicle, LV-CAPON-L-GFP + PDTC) with 10 animals in each group. The investigators involved in data analysis were blinded to the sample identity. No mice were excluded. After completion of the behavioral tests, the brains of the mice were collected for lentiviral infection analysis. The hippocampus of the mice were immediately isolated for further biochemical analysis.
Drugs and intra-hippocampal infusions
Corticosterone (CORT, Cat#27840; Sigma-Aldrich, St Louis, MO, USA) and pyrrolidine dithiocarbamate salt (PDTC, Cat#71935; Sigma-Aldrich) were dissolved in dimethylsulfoxide and sterile physiological saline, respectively. CORT (10 lM) and PDTC (10 lM) were delivered into the dentate gyrus of the hippocampus by microinjection through a pre-implanted cannula as described previously (Lin et al. 2017) . To reduce the animals' suffering, before cannula implantation, adult mice were anesthetized with 0.07 mL of a mixture of ketamine (90.9 mg/mL) and xylazine (9.1 mg/mL). In addition, after the operation, antibiotics (0.2% penicillin and streptomycin, Cat# 15140122; Gibco, Grand Island, NY) were dripped into the surgical incisions. For the intra-hippocampal infusions, the stainless steel guide cannulae (26 gauge, 3.5 mm; RWD Life Science Co., Ltd, Shenzhen, China) were implanted into the DG of the hippocampus (coordinates: 2.3 mm posterior to bregma, 1.3 mm lateral to the midline, and 2.0 mm below the dura) and then fixed to the skull with acrylic dental cement. Intrahippocampal injections were performed by means of an injection cannula (30 gauge, 4.0 mm; RWD Life Science Co., Ltd) terminating 0.50 mm below the tip of the guides and connected by polyethylene tubing (PE-10) to a 10 lL Hamilton syringe. Administration was controlled by an infusion pump programmed to deliver a volume of 1 or 0.5 lL at a flow-rate of 0.1 lL per min. The injection cannulae were left in place for 5 min to allow the drugs to diffuse from the cannula tips. The stainless steel obturators were subsequently reinserted into the guide cannulae. Drug treatment experiments were performed in the animal center between 9 and 11 a.m.
Chronic mild stress and behavioral tests
The CMS procedure and behavioral tests were designed as described in our previous studies (Zhou et al. 2007; Zhang et al. 2010 Zhang et al. , 2016 Zhu et al. 2014) , with minor modifications. The behavioral tests included NSF, the EPM test, and the open-field test. After each trial, the plate was cleaned with 70% EtOH. All the mice were measured approximately 24 h after the last injection of drugs. Behavioral tests were performed during light cycle. During experiments and analysis, the investigators were blinded to the treatment group. The mice were identified by earmarks and were given their numbers only after finishing the behavioral experiments and analysis.
Culture of hippocampal neurons
Primary hippocampal neurons were cultured as reported previously (Zhang et al. 2010; Zhou et al. 2011) , with minor modifications. In brief, the hippocampi of P0 ICR mice were freshly isolated and enzymatically dissociated in calcium-and magnesium-free Dulbecco's phosphate-buffered saline (DPBS) (Cat#14040133; Gibco) containing 0.125% trypsin (Cat# 25200056; Gibco) at 37°C for 10 min. Then, the digestion was terminated with Dulbecco's modified Eagle's medium/F12 (Cat#11330032; Gibco) (1 : 1) containing 10% Fetal Bovine Serum (FBS) (Cat#10091-148; Gibco). Dissociated cells were centrifuged, resuspended in Neurobasal-A medium (Cat#10888-022; Gibco) containing 2% B27 supplement (Cat#17504044; Gibco), 1% GlutaMAX TM -1 (Cat#35050061; Gibco), and 0.2% penicillin and streptomycin (Cat# 15140122; Gibco), and plated on 10 lg/mL polyornithine (Cat#P3655; Sigma-Aldrich)-coated dishes at 1 9 10 5 cells/cm 2 . Half of the medium was replaced with fresh Neurobasal-A/B27 medium every 2-3 days.
Western blot analysis
Western blot analysis of samples from cultured hippocampal neurons and hippocampal tissues from animals was performed as described previously (Zhou et al. 2011; Zhu et al. 2014) . The primary antibodies used were as follows: mouse anti-nNOS (1 : 1000; Cat# 610308, RRID:AB_397700; BD Transduction Laboratories, Franklin Lakes, NJ), rabbit anti-nNOS (1 : 2000; Cat# AB5380, RRID:AB_91824; Millipore Bioscience Research Reagents, Temecula, CA, USA), rabbit anti-CAPON (1 : 1000; Cat# sc-9138, RRID:AB_2251417; Santa Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-Dexras1 (1 : 10 000; Cat# AB15794 RRID:AB_916336; Millipore Bioscience Research Reagents), rabbit anti-p65 (1 : 4000; Cat# ab31481 RRID: AB_2300947; Abcam, MA, USA), rabbit anti-p65 (1 : 1000; Cat #ab16502, RRID:AB_443394; Abcam), rabbit anti-p50 (1 : 500; Cat# ab7971 RRID:AB_306185; Abcam), rabbit anti-phospho-p65-Ser468 (1 : 1000; Cat# 3039, RRID:AB_330579; Cell Signaling Technology, Beverly, MA, USA), rabbit anti-Acetyl-p65-Lys310 (1 : 1000; Cat# 12629, RRID:AB_2722509; Cell Signaling Technology), and rabbit anti-IjBa (1 : 5000; Cat# ab32518, RRID: AB_733068; Abcam). Internal control was performed using b-actin antibody (1 : 1000; Cat# 4970, RRID:AB_2223172; Cell Signaling Technology), b-actin antibody (1 : 10 000; Cat# ab8227, RRID: AB_2305186; Abcam), or Histone H3 antibody (1 : 500; Cat# ab61251, RRID:AB_941952). Appropriate horseradish peroxidaselinked secondary antibodies were used for detection by enhanced chemiluminescence (Cat#34577; Thermo Fisher Scientific, Waltham, MA). In statistical analysis, the protein level of the control group was always defined as 100%, and chemifluorescence was detected by ChemiDoc TM XRS+ Imaging system (Bio-Rad Laboratories, Hercules, CA, USA). Each sample was repeated three times.
Co-immunoprecipitation
The co-immunoprecipitation assay was performed as described previously Zhu et al. 2014) , with minor modifications. The hippocampus of mice were homogenized in ice-cold lysis buffer A (Cat# R0278; Sigma-Aldrich). After lysis for 30 min, samples were centrifuged at 20 000 g for 15 min. The supernatant were pre-incubated for 1 h at 4°C with 0.02 mL of protein G-Sepharose beads (Cat# P4691; Sigma-Aldrich) and then centrifuged to remove proteins that adhered non-specifically to the beads and obtain the target supernatant for the following IP experiment. Protein G-Sepharose beads were incubated with antibody (mouse antibody to nNOS, Cat# 610308, RRID: AB_397700, 5 lg; BD Transduction Laboratories) for 3-4 h. The antibody-conjugated protein G-Sepharose beads and the target supernatant were combined for incubation overnight. The complexes were isolated by centrifugation, washed four times with 0.05 M HEPES buffer pH 7.1 containing 0.15% Triton X-100 and 0.15 M NaCl, and bound proteins were eluted by heating at 100°C in loading buffer. Proteins were analyzed by immunoblotting.
Nuclear and cytoplasmic extraction
The nuclear and cytoplasmic extraction were performed according to the manufacturer's protocol (for cultured cells: Cat#71183-3; EMD Millipore Temecula, CA, USA; for tissue: Cat#78833; Thermo Fisher Scientific). Proteins were analyzed by immunoblotting.
Recombinant lentivirus and stereotaxic injection
A recombinant lentivirus, LV-CAPON-L-GFP, was constructed and synthesized by Shanghai GeneChem Co., Ltd. (Shanghai, China) as described previously (Zhu et al. 2014) . Intra-hippocampal microinjection of the recombinant lentivirus was carried out using a stereotaxic instrument as described previously (Zhu et al. 2014) . Two to 3 weeks after microinjection, the mice were anesthetized and transcardially perfused with 0.9% NaCl followed by 4% paraformaldehyde, and their brains were sectioned at 40 lm thickness using a vibratome (VT1000s; Leica, Mannheim, Germany). Brain slices were blocked in PBS containing 3% normal goat serum, 0.3% Triton X-100, and 0.1% bovine serum albumin at room temperature for 1 h, followed by incubation with rabbit anti-GFP primary antibody (1 : 800; Cat#ab290, RRID:AB_303395; Abcam) at 4°C overnight. Subsequently, the slices were incubated with goat anti-rabbit AlexaFluor 488 secondary antibody (1 : 400; Cat# 111-545-003, RRID: AB_2338046; Jackson Immuno-Research, West Grove, PA, USA) for 2 h at 25°C. Images were captured with a confocal laser-scanning microscope (LSM700; Carl Zeiss, Oberkochen, Germany).
Immunocytochemistry
The details of the immunofluorescence assay for cultured neurons have been reported previously (Zhu et al. 2014) . Neurons at 7 DIV were treated with 10 lM CORT or vehicle for 3 days. At 10 DIV, neurons were fixed and incubated with primary antibodies overnight at 4°C, followed by incubation with the secondary antibodies for 2 h at room temperature. The primary antibodies used were as follows: rabbit anti-p65 (1 : 1000; Cat #ab16502, RRID:AB_443394; Abcam) and chicken anti-MAP2 (1 : 5000; Cat# NB300-213, RRID:AB_2138178; Novus, CO, USA). The secondary antibodies used were goat anti-rabbit Cy3 (1 : 200; Cat#111-165-003, RRID: AB_2338000; Jackson ImmunoResearch Laboratories) and goat anti-chicken Alexa-488 (1 : 400; Cat# 103-545-155, RRID: AB_2337390; Jackson ImmunoResearch Laboratories). Finally, the cultures were counter-stained with DAPI (Cat# D9564; SigmaAldrich) to label the nuclei. Images were captured with a confocal laser-scanning microscope (LSM700; Carl Zeiss, Oberkochen, Germany) at identical settings for each of the conditions.
Golgi-Cox staining
Golgi-Cox staining was performed as described previously (Zhu et al. 2014) . Fresh, non-perfused brains were used for Golgi-Cox staining with FD Rapid GolgiStain Kit (Cat# PK401; FD NeuroTechnologies, MD, USA) according to the user manual, and the brains were cut into 100-lm coronal sections using a vibratome (VT1000s; Leica). To calculate the spine density of Golgi-stained neurons in the DG, a length of a dendrite was traced, the exact length of the dendritic segment was calculated, and the number of spines along the dendritic segment was counted. Ten random neurons in each sample were measured, and the average was regarded as the final value for one sample.
Corticosterone measurement
The corticosterone measurement was performed as described previously (Zhou et al. 2011) . Corticosterone in plasma was measured with a corticosterone ELISA kit according to the instructions from the manufacturer (Cat# 501320; Cayman Chemical, Michigan, USA).
Statistical analysis
Data are presented as the mean AE SEM. The sample size was predetermined by analyzing our pre-experimental data with PASS (power analysis and sample size) software and our prior experience (Zhou et al. 2011; Hu et al. 2012; Zhu et al. 2014; Lin et al. 2017) . Using the pre-experimental data of time spent in the open arms for mice treated with LV-CAPON-L-GFP or LV-GFP in combination with 10 lM PDTC, we obtained the mean AE SD (38.8 AE 10.98, 23.6 AE 10.73, 43.4 AE 10.11 for the LV-GFP, LV-CAPON-L-GFP, LV-CAPON-L-GFP+PDTC groups, respectively). Allowing a type I error of 5%, a = 0.05 with power of 90.9%, we calculated a size of nine animals per group. An assessment of the normality of the data was carried out by the Shapiro-Wilk test before the statistical tests. Using pre-established inclusion and exclusion criteria, mice with normal locomotor activity were included, and the values were excluded from the analyses if the viral injection or drug delivery sites were not within the hippocampus. Outliers were identified using 3 SD method: if a value was greater than the mean + 3 SD or less than the mean À 3 SD, that value was considered an outlier. If the value had no obvious logical error, and the analyses obtained before and after deleting this suspicious value were consistent, it was not excluded. Statistical analysis was performed using Stata software (version 7.0, StataCorp, Texras, USA). Comparisons among multiple groups were made with one-way ANOVA (one factor), followed by Scheffe's post hoc test. Comparisons between two groups were made with two-tailed Student's t-test. Differences were considered significant when p < 0.05. Investigators were blinded to the treatment groups when assessing the outcomes.
Results
Chronic stress activates NF-jB signaling To investigate whether NF-jB signaling is implicated in anxiety disorders, we used CMS, an unpredictable chronic stress condition leading to anxiety-like behaviors, as the animal model of anxiety and examined the expression of NFjB subunits p50 and p65 in the hippocampus of adult male ICR mice exposed to CMS for 21 days. We found that CMS significantly induced up-regulation of the expression of p50 (F 1,4 = 14.63, p = 0.0187) and p65 (F 1,4 = 22.33, p = 0.0091) in the hippocampus compared to that of control. However, multiple forms of post-translational modification, such as phosphorylation of p65 at Ser468 (p-p65) and acetylation of p65 at Lys310 (A-p65), are required for the transcriptional activity of NF-jB. We therefore examined levels of p-p65 and A-p65 in the hippocampus of adult male ICR mice after CMS exposure. CMS exposure significantly increased levels of p-p65 (for p-p65/b-actin: F 1,4 = 9.85, p = 0.0349; for p-p65/p65: F 1,4 = 0.7, p = 0.4487) and A-p65 (for A-p65/b-actin: F 1,4 = 30.47, p = 0.0053; for A-p65/p65: F 1,4 = 10.53, p = 0.0315) in the hippocampus, implicating chronic mild stress in the activation of NF-jB signaling in the hippocampus (Fig. 1a) .
Our previous study showed that CMS-induced glucocorticoid overproduction modulates stress-related depressive behavior (Zhou et al. 2011) . In this study, we also measured the plasma CORT level of the mice exposed to CMS and found that CMS significantly increased the CORT level (Fig. 1b) (F 1,8 = 30 .85, p = 0.001), in line with a previous report (Zhou et al. 2011) . Therefore, we used CORT treatment to mimic CMS exposure and tested whether CORT modulates NF-jB signaling as CMS does. To test this notion, we microinfused CORT (10 lM, 1 lL) into the hippocampus of adult male C57BL/6 mice for 21 consecutive days and observed that CORT significantly increased the levels of p50, p65, p-p65, and A-p65 in the hippocampus (Fig. 1c ) (for p50: F 1,4 = 100.70, p = 0.001; for p65: F 1,4 = 49.77, p = 0.0021; for p-p65/b-actin: F 1,4 = 16.61, p = 0.0152; for A-p65/b-actin: F 1,4 = 10.00, p = 0.0341; for p-p65/p65: F 1,4 = 0.6, p = 0.4815; for A-p65/p65: F 1,4 = 5.61, p = 0.077). The IjBa (inhibitor of kappa B) protein inactivates NF-jB by keeping it sequestered in an inactive state in the cytoplasm, so we sought to determine whether CORT regulates NF-jB signaling by increasing the degradation of IjBa and then inducing nuclear translocation of p65. As shown in Fig. 1(d) , intra-hippocampal microinjection of CORT (10 lM, 1 lL) decreased the levels of IjBa in the cytoplasm and increased p65 in the nucleus (for IjBa: F 1,4 = 10.79, p = 0.03; for p65: F 1,4 = 7.93, p = 0.048).
Next, we incubated hippocampal neurons with 10 lM CORT for 24, 48, and 72 h and found that this treatment significantly increased p50, p65, p-p65, and A-p65 levels after exposure for 48 or 72 h (for p50: (Fig. 2a) . More importantly, 10 lM CORT exposure for 48 or 72 h significantly reduced the cytosolic content of IjBa and increased nuclear levels of p65, as shown by the results of western blot analysis using nuclear extract (Fig. 2b ) (for IjBa: F 2,6 = 90.55, for 48 h, p = 0.001, for 72 h, p < 0.001; for p65: F 2,6 = 29.25, for 48 h, p = 0.015, for 72 h, p = 0.001). Consistent with these results, there was a marked increase in the translocation of p65 to the nucleus when the hippocampal neurons were stimulated with 10 lM CORT for 72 h (Fig. 2c) . Together, these results indicate that glucocorticoids activate NF-jB signaling in the hippocampus.
Hippocampal NF-jB mediates chronic stress-induced anxiogenic behaviors To examine whether NF-jB is implicated in chronic stressinduced anxiety behaviors, we exposed adult male ICR mice to CMS for 21 days and delivered pyrrolidine dithiocarbamate (PDTC; 10 lM, 1 lL), an inhibitor of NFjB signaling, into the hippocampus of mice through microcannulae for 21 consecutive days starting the day before CMS exposure. Consistent with our previous work (Zhu et al. 2014) , the mice exposed to CMS exhibited significantly increased latency to feed in a novel environment in the NSF test and spent less time in the open arms in the EPM test, suggesting a typical anxiogenic phenotype (Fig. 3b-c and e) . Notably, treatment with PDTC substantially reversed the CMS-induced increase in latency to feed in the NSF test (F 2,28 = 5.61, CMS + vehicle vs. Vehicle: p = 0.019; CMS + PDTC vs. CMS + vehicle: p = 0.033) and reduction in time spent in the open arms in the EPM test (F 2,28 = 10.81, CMS + vehicle vs. Vehicle: p < 0.001; CMS + PDTC vs. CMS + Vehicle: p = 0.044), indicating anxiolytic effects (Fig. 3b-c and e) . Moreover, this treatment had no effect on the latency to feed in home cages or the amount of home cage food consumption, the number of entries in the total arms or open arms, and locomotor activity in the NSF, EPM, and open-field (OF) tests, respectively (for total arms: F 2,28 = 1.14, p = 0.3351; for open arms: F 2,28 = 0.82, p = 0.4513; for the latency to feed in home cage: F 2,28 = 2.00, p = 0.1538; for the amount of home cage food consumption: F 2,28 = 1.38, p = 0.2676; for horizontal activity: F 2,28 = 2.08, p = 0.1439; for vertical activity: F 2,28 = 1.62, p = 0.2163) (Fig. 3b and d-h) .
To further confirm the role of NF-jB in chronic stressinduced anxiety behaviors, we infused CORT (10 lM, 0.5 lL) with or without PDTC (10 lM, 0.5 lL, administered 30 min before CORT) into the hippocampus of adult male C57BL/6 mice for 21 consecutive days via preimplanted cannulae. Similar to CMS exposure, chronic treatment with CORT also produced anxiogenic behaviors in the NSF and EPM tests (Fig. 4b-c vs. CORT + vehicle: p = 0.045; for the latency to feed: F 2,31 = 8.44, CORT + vehicle vs. Vehicle: p = 0.002; CORT + PDTC vs. CORT + vehicle: p = 0.027) (Fig. 4b-c and e) . However, intra-hippocampal PDTC microinjection did not alter the effect of CORT on the number of entries into the open arms (Fig. 4d) . In addition, treatment with CORT, PDTC, or both in combination did not affect the latency to feed in home cages or the amount of home cage food consumption, the number of entries in the total arms, and locomotor activity in the NSF, EPM, and OF tests, respectively (Fig. 4d-h ) (for total arms: F 2,31 = 2.36, p = 0.1112; for latency: F 2,31 = 0.05, p = 0.9526; for food consumption: F 2,31 = 1.05, p = 0.3625; for horizontal activity: F 2,31 = 0.33, p = 0.7222; for vertical activity: F 2,31 = 0.02, p = 0.9850). Collectively, these data strongly indicate a significant implication of hippocampal NF-jB signaling in anxiety-related behaviors.
Hippocampal NF-jB mediates chronic stress-induced anxiogenic behaviors via augmenting nNOS-CAPONDexras1 interaction Our previous study demonstrated that CMS or CORT enhances nNOS-CAPON association in the hippocampus and thus produces anxiogenic effects via activating Dexras1-ERK signaling and regulation of hippocampal synaptic plasticity (Zhu et al. 2014 ). Dexras1, dexamethasoneinduced ras protein 1, binds to the N-terminal phosphotyrosine-binding domain of CAPON and is activated by nNOSmediated S-nitrosylation (Fang et al. 2000; Zhu et al. 2014) . We thus investigated whether NF-jB mediates CMS-or CORT-induced anxiety disorders via regulating nNOS-CAPON-Dexras1 binding. First, we examined the expression of nNOS, CAPON, and Dexras1 in the cultured hippocampal neurons exposed to 1.0 or 10 lM PDTC for 24 h. The drug dramatically reduced levels of nNOS (F 2,9 = 38.42, p < 0.001), CAPON (F 2,9 = 16.94, p < 0.001), and Dexras1 (F 2,9 = 11.72, p = 0.0031) in a concentration-dependent manner (Fig. 5a) .
Next, we incubated hippocampal neurons with CORT (10 lM) for 72 h in the presence of 0 or 10 lM PDTC. As expected, CORT increased the expression of nNOS, CAPON, and Dexras1, and PDTC significantly abolished the effect of CORT (For nNOS: F 2,9 = 31.24, CORT + vehicle vs. Vehicle: p < 0.001; CORT + PDTC vs. CORT + vehicle: p = 0.001. For CAPON: F 2,9 = 7.88, CORT + vehicle vs. Vehicle: p = 0.027; CORT + PDTC vs. CORT + vehicle: p = 0.020. For Dexras1: F 2,9 = 6.37, CORT + vehicle vs. Vehicle: p = 0.035; CORT + PDTC vs. CORT + vehicle: p = 0.043) (Fig. 5b) . To further determine whether NF-jB signaling modulates the expression of nNOS, CAPON, and Dexras1 in anxiety disorders, we measured the levels of nNOS, CAPON, and Dexras1 in the hippocampus of adult male ICR mice exposed to CMS for 21 days with or without PDTC (10 lM, 1 lL). We found that PDTC reversed CMS-induced up-regulation of nNOS, CAPON, and Dexras1 expression (For nNOS: F 2,6 = 11.73, CMS + vehicle vs. Vehicle: p = 0.014; CMS + PDTC vs. CMS + vehicle: p = 0.020. For CAPON: F 2,6 = 16.51, CMS + vehicle vs. Vehicle: p = 0.005; CMS + PDTC vs. CMS + vehicle: p = 0.013. For Dexras1: F 2,6 = 10.53, CMS + vehicle vs. Vehicle: p = 0.014; CMS + PDTC vs. CMS + vehicle: p = 0.038) (Fig. 5c) . Thus, the activation of NF-jB is required for CMS or CORT to exert an effect on the expression of nNOS, CAPON, and Dexras1. Considerable evidence has shown that anxiety is related to neuroanatomic changes in the hippocampus (Lonetti et al. 2010; Soetanto et al. 2010; Mucha et al. 2011) . We previously identified that hippocampal nNOS-CAPON signaling influences dendritic spine density and length and the branching of dendrites (Zhu et al. 2014) . To investigate the effects of NF-jB on hippocampal structural synaptic plasticity, we detected the dendritic spine density of hippocampal DG granule cells of adult male ICR mice exposed to CMS for 21 days with or without PDTC (10 lM, 1 lL). The results indicated that treatment with PDTC rescued CMS-induced dendritic spine loss of DG granule cells (F 2,9 = 15.66, CMS + vehicle vs. Vehicle: p = 0.001; CMS + PDTC vs. CMS + vehicle: p = 0.013) (Fig. 5d) .
Previously, we have shown that augmenting nNOS-CAPON interaction by over-expressing CAPON in the hippocampus produced anxiogenic-like behaviors (Zhu et al. 2014) . To test whether inhibition of NF-jB signaling reverses the anxiogenic behavior induced by over-expressing CAPON, we generated a recombinant lentiviral vector selectively expressing full-length CAPON (CAPON-L) and named it LV-CAPON-L-GFP. We infused LV-CAPON-L-GFP or its control LV-GFP into the hippocampus of adult male C57BL/6 mice, and 3 days later, we delivered PDTC (10 lM, 1 lL) into the hippocampus daily via injection cannula for 14 consecutive days and measured the level of nNOS-Dexras1 complex and anxiety-related behaviors approximately 24 h after the last PDTC injection. As expected, LV-CAPON-L-GFP effectively infected the hippocampal dentate gyrus (Fig. 5f1 and f2) , produced considerable CAPON-L-GFP (Fig. 5f3) , increased the amount of nNOS-Dexras1 complex (Fig. 5f) , and caused mice to display a typical anxiogenic-like phenotype (for latency to feed in a novel environment: F 2,27 = 7.73, LV-CAPON-L-GFP + vehicle vs. LV-GFP + vehicle: p = 0.006; for time spent in open arms: F 2,27 = 6.73, LV-CAPON-L-GFP + vehicle versus LV-GFP + vehicle: p = 0.006) (Fig. 5g and i) . Co-immunoprecipitation data showed that LV-CAPON-L-GFP infection increased the amount of nNOS-Dexras1 complex, and PDTC reversed the CAPON over-expression-induced association of nNOS with Dexras1 in the hippocampus (Fig. 5f ). The reduction in nNOSDexras1 interaction could be because of PDTC-elicited decreases in nNOS and Dexras1. More importantly, treatment with PDTC rescued the anxiogenic-like effects of LV-CAPON-L-GFP in the NSF test and EPM test (for latency to feed in a novel environment: F 2,27 = 7.73, LV-CAPON-L-GFP + PDTC vs. LV-CAPON-L-GFP + vehicle: p = 0.012; for time spent in open arms: F 2,27 = 6.73, LV-CAPON-L-GFP + PDTC vs. LV-CAPON-L-GFP + vehicle: p = 0.048) (Fig. 5g and i) . No differences were observed in the latency to feed in home cage (F 2,27 = 0.11, p = 0.8956) or the amount of food consumption (F 2,27 = 0.73, p = 0.4898) in the home cage in the NSF test, the number of entries in total (F 2,27 = 0.17, p = 0.8417) or open arms (F 2,27 = 1.22, p = 0.3115) in the EPM test, or the locomotor activity (for horizontal: F 2,27 = 0.12, p = 0.8876; for vertical: F 2,27 = 1.05, p = 0.3642) in the open-field test (Fig. 5h-k) . Thus, hippocampal NF-jB mediates stress-induced anxiogenic-like behaviors through enhancing nNOS-CAPON-Dexras1 interaction.
Discussion
Despite a large amount of evidence indicating that NF-jB is involved in the regulation of anxiety behavior (Kassed and Herkenham 2004; Lehmann et al. 2010; Cohen et al. 2011; Fan et al. 2016) , the mechanisms by which NF-jB modulates anxiety behaviors are not clear. In this study, we revealed a signaling cascade whereby chronic stress activates hippocampal NF-jB signaling, enhances the expression and association of nNOS, CAPON, and Dexras1, and thus leads to anxiety-related behaviors.
nNOS, which is mainly expressed in neurons and is responsible for NO production in the CNS (Bredt and Snyder 1994) , is implicated in the regulation of emotional behaviors (Zhou and Zhu 2009; Zhou et al. 2011; Zhu et al. 2014) . In this study, we selected neurons as target cells and found that suppression of NF-jB signaling by PDTC markedly reduced nNOS levels in a concentration-dependent manner. Notably, our results also showed that inhibition of NF-jB reversed CMS-or CORT-induced up-regulation of CAPON and Dexras1 expression, two proteins that bind to nNOS and then form a ternary complex of nNOS-CAPON-Dexras1. This complex was reported to mediate the stress-induced anxiety behaviors by ERK signaling and hippocampal synaptic plasticity (Zhu et al. 2014) . Our results are in accordance with the findings that promoting NF-jB nuclear translocation and activation can result in transcriptional activation of the nNOS gene (Napolitano et al. 2008) . In addition, some researchers reported that direct acetylation of NF-jB increases nNOS expression and NO formation via enhancing the binding of NF-jB to the nNOS promoter (Li et al. 2007 (Li et al. , 2013 . Reportedly, NF-jB activates NF-jB response element (RE)-containing latent enhancers of the target genes (Kuznetsova et al. 2015) , which may be the reason NF-jB signaling promotes the expression and association of nNOS, CAPON, and Dexras1. Phosphorylation of IjBa triggers its ubiquitination and degradation, promotes p65 to enter the nucleus and thus results in heightened transcriptional activity of NF-jB (Karin 1999) . Our results showed that CORT reduced the level of IjBa in the cytoplasm and increased p65 in the nucleus, implying enhancement of NF-jB transcriptional activity. Additionally, there are also numerous post-translational modifications that regulate the activity and function of NF-jB, including phosphorylation, ubiquitination, acetylation, sumoylation, and nitrosylation (Perkins 2006) . Here, we only examined the phosphorylation of p65 at Ser468 and acetylation of p65 at Lys310, key modifications in regulating NF-jB activity (Buss et al. 2004a; Perkins 2006; Lanzillotta et al. 2010) . It is reported that phosphorylation of p65 at Ser-468 is inducible in response to pro-inflammatory cytokines, including tumor necrosis factor and interleukin-1b (IL-1b), and that IKKɛ-mediated phosphorylation at Ser468 stimulates p65 transactivation (Mattioli et al. 2006; Perkins 2006) . Phosphorylation of p65 can stimulate acetylation of p65 at the Lys-310 site (Chen et al. 2005) , which also enhances p65 transactivation (Chen et al. 2002) . In this study, we showed that CMS or CORT increases the levels of phosphorylation of p65 at Ser-468 and acetylation of p65 at Lys310 and promotes p65 nuclear translocation, implying that CMS or CORT enhanced the transcriptional activity of NF-jB. This is consistent with a previous study showing that chronic unpredictable mild stress induced NF-jB activation by enhanced phosphorylation of p65 (Su et al. 2017) . However, other post-translational modifications regulating NF-jB function and thereby affecting nNOS, Dexras1, and CAPON expression need to be further investigated.
The role of NF-jB in emotional behaviors is only beginning to be researched (Kassed and Herkenham 2004; Koo et al. 2010; Cohen et al. 2011 ). In line with other studies reporting that NF-jB subunit p50-deficient mice The latency to feed in a novel environment and in the home cage (i) and food consumption in the home cage (j) in the novelty-suppressed feeding test in adult male C57BL/6 mice treated with intra-hippocampal microinjection of LV-CAPON-L-GFP or LV-GFP in combination with 10 lM PDTC or its vehicle. (k) The locomotor activity in the open-field test. Parameters for the locomotor activities were the number of square crossings (horizontal) and the time standing (vertical). In (f-k) PDTC (10 lM, 1 lL) or its vehicle was infused into the hippocampus of the adult mice via injection cannula for 14 consecutive days on day 4 after LV-CAPON-L-GFP or LV-GFP was microinjected into the hippocampus. The behaviors in (g-k) (n = 10 mice) were assessed 1 day after the last treatment. Mean AE SEM, *p < 0.05, **p < 0.01, ***p < 0.001, oneway ANOVA (a-d, g-k) . Scale bar, 100 lm. CAPON, carboxy-terminal PDZ ligand of nNOS; CMS, chronic mild stress; Dexras1, dexamethasone-induced ras protein 1; LV, lentivirus; PDTC, pyrrolidine dithiocarbamate.
display anxiolytic-like behaviors (Kassed and Herkenham 2004) , we found that microinjection of NF-jB inhibitor PDTC into the hippocampus reversed CMS-or CORTinduced anxiogenic behaviors. In this study, we showed that hippocampal NF-jB modulated chronic stress-induced anxiety behaviors by promoting the association of nNOS, CAPON, and Dexras1 in the hippocampus, which was previously verified to regulate hippocampal synaptogenesis (Zhu et al. 2014) . Increasing evidence shows that anxiety is associated with neuroanatomic changes in the hippocampus, including dendritic spine density, and length and branching of dendrites (Lonetti et al. 2010; Soetanto et al. 2010; Mucha et al. 2011) . In agreement with these findings, our current study also demonstrated that after 3 weeks of CMS exposure, the number of dendritic spines in hippocampal DG granule cells was reduced. In addition, inhibition of NF-jB by PDTC rescued CMS-induced dendritic spine loss. Others have shown that pharmacological inhibitors of NF-jB regulate hippocampal cell proliferation (Koo et al. 2010; Monje et al. 2011) . In addition to the proliferative actions of NF-jB, there is also evidence that NF-jB activity regulates spine density and glutamatergic synapse formation (Boersma et al. 2011; Kaltschmidt and Kaltschmidt 2015) . In addition, specific ablation of NF-jB subunits in neurons confirmed the role of NF-jB in neurogenesis and the function of NF-jB in dentate gyrus homeostasis, synaptogenesis, and axogenesis (Imielski et al. 2012) . Our findings on NF-jB affecting dendritic spines at least hint that NF-jB is involved in the structural neuroplasticity of the hippocampus related to anxiety behaviors.
However, accumulating evidence suggests that stress enhanced the inflammatory effects of NF-jB, thereby mediating emotional behaviors (Madrigal et al. 2001; Kassed and Herkenham 2004; Munhoz et al. 2006; LaPlant et al. 2009; Koo et al. 2010; Lehmann et al. 2010; Cohen et al. 2011; Oikawa et al. 2012; Bortolotto et al. 2014) . Chronic stress activated the inflammatory response by NFjB signaling, and then induced depressive-like behaviors, while blockade of NF-jB could inhibit the actions of proinflammatory cytokines and exhibit an antistress effect (Koo et al. 2010) . Furthermore, there is also evidence demonstrating that hippocampal NF-jB activation may trigger the proinflammatory response of microglial cells and be involved in the anxiolytic effect in chronic normobaric hypoxia-exposed rats (Fan et al. 2016) . A recent study showed that acute psychosocial stress increased the DNA-binding activity of NF-jB in peripheral blood mononuclear cells (Kuebler et al. 2015) . Interestingly, here, we found that CORT exposure markedly activated NF-jB in cultured neurons, as indicated by increased levels of phosphorylated and acetylated p65, and promoted p65 nuclear translocation. This finding provides an example of how stress or glucocorticoid exposure results in activation of NF-jB in a population of cells, the neurons; although it seems that, the enhanced phosphorylation and acetylation of p65 are the results of upregulation of p65 induced by CORT exposure.
Here, we analyzed the neural substrates of anxiety via investigating behavioral tasks that measure responses induced by stimuli that are naturally aversive to mice. Tests used to assess anxiety responses include avoidance of the exposed open arms of the EPM and the exposed center of a novel open field in NSF. We also quantitated the locomotor activity to show that the drug effects are specific to anxietyrelated behaviors. However, these tests are commonly used to measure spontaneous behaviors and might be influenced by variations in test procedure and environment, such as strain differences, gender, and housing conditions (Cryan and Holmes 2005) . In this study, the inbred C57BL/6 and outbred ICR strains of adult male mice were used in anxiety-like behavioral tests, which are the most widely used strains in behavioral tests. A growing number of studies have begun to use stress-based animal models to explore anxiety and depressive disorders (Zhou et al. 2011; Zhu et al. 2014) . We selectively used the ICR strain of mice in the CMS procedure to model anxiety, mainly because of the evidence that C57BL/6 mice, when subjected to CMS, show controversial phenotypes in depressive behaviors characterized by a decrease in immobility in the tail suspension test and increased immobility in the forced swimming test, whereas ICR mice display anxiety-like but not depressive-like behaviors after CMS exposure (Mineur et al. 2006; Jung et al. 2014) .
This study reveals the role of hippocampal NF-jB signaling in anxiety-related behaviors and offers a novel intervention target for the treatment of anxiety disorder. However, a limitation of this work is that PDTC was given before the period of CMS or CORT exposure, rather than after CMS or CORT exposure, suggesting that this treatment would be a preventive treatment for anxiety-related disorders. Therefore, it warrants further investigation of whether and how inhibition of NF-jB signaling after CMS or CORT exposure could produce anxiolytic effects.
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